12.91

2.54% 0.32

After Hours: 12.50 -0.41 -3.18%

Delcath Systems Inc (DCTH)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Delcath Systems Inc stock is traded at $12.91, with a volume of 390.31K. It is up +2.54% in the last 24 hours and up +21.79% over the past month. Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Previous Close:

$12.59

Open:

$12.62

24h Volume:

390.31K

Relative Volume:

0.86

Market Cap:

$445.67M

Revenue:

$90.44M

Net Income/Loss:

$561.00K

P/E Ratio:

2,151.67

EPS:

0.006

Net Cash Flow:

$19.19M

1W Performance:

+5.47%

1M Performance:

+21.79%

6M Performance:

+27.82%

1Y Performance:

+1.18%

1-Day Range:

$12.46

$13.12

1-Week Range:

$12.14

$13.19

52-Week Range:

$8.12

$13.44

Delcath Systems Inc Stock (DCTH) Company Profile

Name

Delcath Systems Inc

Sector

Healthcare (1093)

Industry

Medical Devices (138)

Phone

(518) 743-8892

Address

566 QUEENSBURY AVENUE, QUEENSBURY, NY

Employee

156

Twitter

@delcathsystems

Next Earnings Date

2026-08-05

Latest SEC Filings

DCTH's Discussions on Twitter

Compare DCTH vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
DCTH Delcath Systems Inc	12.91	434.63M	90.44M	561.00K	19.19M	0.006
ABT Abbott Laboratories	92.18	158.05B	45.13B	6.28B	7.38B	3.5895
SYK Stryker Corp	313.39	120.70B	25.27B	3.34B	4.57B	8.6334
MDT Medtronic Plc	79.20	100.14B	36.36B	4.84B	5.43B	3.7212
BSX Boston Scientific Corp	43.06	63.44B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	91.99	52.09B	6.30B	1.07B	1.09B	1.8406

Delcath Systems Inc Stock (DCTH) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jun-28-24	Initiated	Craig Hallum	Buy
May-14-24	Initiated	Stephens	Overweight
Jul-26-22	Resumed	Canaccord Genuity	Buy
Dec-10-21	Initiated	H.C. Wainwright	Buy
Mar-09-21	Initiated	Canaccord Genuity	Buy
Jan-05-21	Initiated	BTIG Research	Buy
Jun-01-20	Initiated	Laidlaw	Buy

View All

Delcath Systems Inc Stock (DCTH) Latest News

Jun 30, 2026

Avoiding Lag: Real-Time Signals in (DCTH) Movement - Stock Traders Daily

Jun 30, 2026

Jun 29, 2026

Delcath Systems, Inc.(NasdaqCM:DCTH) added to Russell Microcap Value Benchmark Index - marketscreener.com

Jun 29, 2026

Delcath Systems, Inc.(NasdaqCM: DCTH) added to Russell 2000 Value Benchmark - marketscreener.com

Jun 29, 2026

Price to book forward of Delcath Systems, Inc. – SWB:DV3R - TradingView

Jun 29, 2026

Jun 28, 2026

Delcath Systems, Inc.(NasdaqCM: DCTH) added to Russell 2000 Value-Defensive Index - marketscreener.com

Jun 28, 2026

Price to earnings forward of Delcath Systems, Inc. – NASDAQ:DCTH - TradingView

Jun 28, 2026

Enterprise value to revenue forward of Delcath Systems, Inc. – SWB:DV3R - TradingView

Jun 28, 2026

Delcath Systems, Inc.(NasdaqCM: DCTH) added to Russell 2000 Growth-Defensive Index - marketscreener.com

Jun 28, 2026

Enterprise value to EBITDA forward of Delcath Systems, Inc. – NASDAQ:DCTH - TradingView

Jun 28, 2026

Delcath Systems (DCTH) Surges 5.6% on Above-Average Volume, Tests Key ResistanceChart Pattern Alerts - dars.gov.et

Jun 23, 2026